Lipid lowering versus pleiotropic effects of statins on skin microvascular function in patients with dysglycaemia and coronary artery disease

Journal of Internal Medicine

Volumn 266, Issue 5, 2009, Pages 492-498

  Settergren, M ^a   Bohm F ^a   Ryden L ^a   Pernow, J ^a   Kalani, M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Ezetimibe; Microvascular function; Pleiotropic effects; Statins; Type 2 diabetes

Indexed keywords

EZETIMIBE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; WARFARIN;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DYSGLYCEMIA; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; HEATING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; VASODILATATION;

AGED; AZETIDINES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOOT; FOREARM; GLUCOSE INTOLERANCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LASER-DOPPLER FLOWMETRY; LIPIDS; MALE; MICROCIRCULATION; SIMVASTATIN; SKIN;

EID: 70349871516     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02128.x     Document Type: Article

References (25)

1. Stratton IM, Cull CA, Adler AI et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006 49 : 1761 1769.
2. Cheung N, Wang JJ, Rogers SL et al. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 2008 51 : 1573 1578.
3. Kearney PM, Blackwell L, Collins R et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008 371 : 117 125.
4. Fegan PG, Shore AC, Mawson D et al. Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy. Diabet Med 2005 22 : 1670 1676.
5. Mansourati J, Newman LG, Roman SH et al. Lipid lowering does not improve endothelial function in subjects with poorly controlled diabetes. Diabetes Care 2001 24 : 2152 2153.
6. Leiter LA. The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabetes Res Clin Pract 2005 68 (Suppl. 2 S3 14.
7. Palinski W. New evidence for beneficial effects of statins unrelated to lipid lowering. Arterioscler Thromb Vasc Biol 2001 21 : 3 5.
8. Davidson MH, McGarry T, Bettis R et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002 40 : 2125 2134.
9. Settergren M, Bohm F, Ryden L et al. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 2008 29 : 1753 1760.
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 (Suppl. 1 S5 20.
11. RG IJ, de Jongh RT, Beijk MA et al. Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest 2003 33 : 536 542.
12. Ledue TB, Weiner DL, Sipe JD et al. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem 1998 35 (Pt 6 745 753.
13. Povoa G, Roovete A, Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 1984 107 : 563 570.
14. Boyko EJ, Ahroni JH, Stensel V et al. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999 22 : 1036 1042.
15. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004 364 : 685 696.
16. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005 46 : 1425 1433.
17. Tamai O, Matsuoka H, Itabe H et al. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997 95 : 76 82.
18. Maki-Petaja KM, Booth AD, Hall FC et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007 50 : 852 858.
19. Kinlay S. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. J Am Coll Cardiol 2007 49 : 2003 2009.
20. Liu PY, Liu YW, Lin LJ et al. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009 119 : 131 138.
21. Kim JA, Montagnani M, Koh KK et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006 113 : 1888 1904.
22. de Jongh RT, Serne EH, RG IJ et al. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004 109 : 2529 2535.
23. Settergren M, Pernow J, Brismar K et al. Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. J Vasc Res 2008 45 : 295 302.
24. Strain WD, Chaturvedi N, Leggetter S et al. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 2005 23 : 133 140.
25. Gooding KM, Hannemann MM, Tooke JE et al. Maximum skin hyperaemia induced by local heating: possible mechanisms. J Vasc Res 2006 43 : 270 277.